Guidelines for the successful generation of protein–ligand complex crystals

This article aims to guide efforts in protein–ligand complex crystal structure generation, with special consideration of protein construct design, and summarizes different approaches to co-crystallization and crystal soaking. Common problems and pitfalls are highlighted.

[1]  J. Nieman,et al.  HIV Capsid is a Tractable Target for Small Molecule Therapeutic Intervention , 2010, PLoS pathogens.

[2]  Y. Zhao,et al.  Atomic structure of PDE4: insights into phosphodiesterase mechanism and specificity. , 2000, Science.

[3]  R. Battistutta,et al.  Different orientations of low-molecular-weight fragments in the binding pocket of a BRD4 bromodomain. , 2013, Acta crystallographica. Section D, Biological crystallography.

[4]  P. Seeburg,et al.  Structural mechanism for STI-571 inhibition of abelson tyrosine kinase. , 2000, Science.

[5]  D. Hirschberg,et al.  Structure and allosteric effects of low-molecular-weight activators on the protein kinase PDK1. , 2009, Nature chemical biology.

[6]  Adam Godzik,et al.  Improving the chances of successful protein structure determination with a random forest classifier. , 2014, Acta crystallographica. Section D, Biological crystallography.

[7]  C. Müller,et al.  Chemical Genetic Analysis and Functional Characterization of Staphylococcal Wall Teichoic Acid 2-Epimerases Reveals Unconventional Antibiotic Drug Targets , 2016, PLoS pathogens.

[8]  良二 上田.  J. Appl. Cryst.の発刊に際して , 1970 .

[9]  S. Knapp,et al.  Family-wide Structural Analysis of Human Numb-Associated Protein Kinases , 2016, Structure.

[10]  A. D'arcy,et al.  Microseed matrix screening for optimization in protein crystallization: what have we learned? , 2014, Acta crystallographica. Section F, Structural biology communications.

[11]  J. Min,et al.  Human HDAC7 Harbors a Class IIa Histone Deacetylase-specific Zinc Binding Motif and Cryptic Deacetylase Activity* , 2008, Journal of Biological Chemistry.

[12]  Hong Cao,et al.  The Molecular Basis of Drug Resistance against Hepatitis C Virus NS3/4A Protease Inhibitors , 2012, PLoS pathogens.

[13]  Victor S. Lobanov,et al.  High-Density Miniaturized Thermal Shift Assays as a General Strategy for Drug Discovery , 2001 .

[14]  Kam Y. J. Zhang,et al.  A glutamine switch mechanism for nucleotide selectivity by phosphodiesterases. , 2004, Molecular cell.

[15]  C. Mattia,et al.  Increasing the X-ray Diffraction Power of Protein Crystals by Dehydration: The Case of Bovine Serum Albumin and a Survey of Literature Data , 2012, International journal of molecular sciences.

[16]  Haruki Nakamura,et al.  Announcing the worldwide Protein Data Bank , 2003, Nature Structural Biology.

[17]  George T Detitta,et al.  Thermofluor-based high-throughput stability optimization of proteins for structural studies. , 2006, Analytical biochemistry.

[18]  E. Pohl,et al.  Structural Basis of allosteric regulation and substrate specificity of the non-phosphorylating glyceraldehyde 3-Phosphate dehydrogenase from Thermoproteus tenax. , 2004, Journal of molecular biology.

[19]  Song Tan,et al.  Comparison of affinity tags for protein purification. , 2005, Protein expression and purification.

[20]  Qing Cao,et al.  Structural determinants for inhibitor specificity and selectivity in PDE2A using the wheat germ in vitro translation system. , 2005, Biochemistry.

[21]  F. Young.  Biochemistry , 1955, The Indian Medical Gazette.

[22]  Robert B. Russell,et al.  GlobPlot: exploring protein sequences for globularity and disorder , 2003, Nucleic Acids Res..

[23]  T. Kinoshita,et al.  Structure of human Fyn kinase domain complexed with staurosporine. , 2006, Biochemical and biophysical research communications.

[24]  G. G. Stokes.  "J." , 1890, The New Yale Book of Quotations.

[25]  J. Doye,et al.  Inhibition of protein crystallization by evolutionary negative design , 2004, Physical biology.

[26]  K. Longenecker,et al.  Protein crystallization by rational mutagenesis of surface residues: Lys to Ala mutations promote crystallization of RhoGDI. , 2001, Acta crystallographica. Section D, Biological crystallography.

[27]  J. Greenwood,et al.  Crystal Structure and Pharmacological Characterization of a Novel N-Methyl-d-aspartate (NMDA) Receptor Antagonist at the GluN1 Glycine Binding Site* , 2013, The Journal of Biological Chemistry.

[28]  J. E. Villafranca,et al.  Studies on engineering crystallizability by mutation of surface residues of human thymidylate synthase , 1992 .

[29]  Armin Ruf,et al.  Molecular switch in the glucocorticoid receptor: active and passive antagonist conformations. , 2010, Journal of molecular biology.

[30]  Tobias Rumpf,et al.  Seeding for sirtuins: microseed matrix seeding to obtain crystals of human Sirt3 and Sirt2 suitable for soaking , 2015, Acta crystallographica. Section F, Structural biology communications.

[31]  Linda Öster,et al.  Successful generation of structural information for fragment-based drug discovery. , 2015, Drug discovery today.

[32]  R. Rosenfeld.  Nature , 2009, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[33]  M. Lamers,et al.  A new apo-caspase-6 crystal form reveals the active conformation of the apoenzyme. , 2011, Journal of molecular biology.

[34]  Brian D. Marsden,et al.  High-throughput production of human proteins for crystallization: The SGC experience , 2010, Journal of structural biology.

[35]  Sameer Velankar,et al.  Genome3D: a UK collaborative project to annotate genomic sequences with predicted 3D structures based on SCOP and CATH domains , 2012, Nucleic Acids Res..

[36]  T. Willson,et al.  Crystal Structure of the Glucocorticoid Receptor Ligand Binding Domain Reveals a Novel Mode of Receptor Dimerization and Coactivator Recognition , 2002, Cell.

[37]  G. Labesse,et al.  Combining 'dry' co-crystallization and in situ diffraction to facilitate ligand screening by X-ray crystallography. , 2015, Acta crystallographica. Section D, Biological crystallography.

[38]  Susan S. Taylor,et al.  Regulation of protein kinases; controlling activity through activation segment conformation. , 2004, Molecular cell.

[39]  Zygmunt S Derewenda,et al.  Application of protein engineering to enhance crystallizability and improve crystal properties. , 2010, Acta crystallographica. Section D, Biological crystallography.

[40]  Doriano Fabbro,et al.  Structural biology contributions to the discovery of drugs to treat chronic myelogenous leukaemia , 2006, Acta crystallographica. Section D, Biological crystallography.

[41]  C. J. Lusty.  A gentle vapor-diffusion technique for cross-linking of protein crystals for cryocrystallography , 1999 .

[42]  Victor H Hernandez,et al.  Nature Methods , 2007 .

[43]  E. Stura,et al.  Transthyretin complexes with curcumin and bromo-estradiol: evaluation of solubilizing multicomponent mixtures. , 2015, New biotechnology.

[44]  I. Wall,et al.  Crystal structures of ASK1‐inhibtor complexes provide a platform for structure‐based drug design , 2013, Protein science : a publication of the Protein Society.

[45]  Patrick Collins,et al.  The XChemExplorer graphical workflow tool for routine or large-scale protein–ligand structure determination , 2017, Acta crystallographica. Section D, Structural biology.

[46]  Daniel W. A. Buchan,et al.  Scalable web services for the PSIPRED Protein Analysis Workbench , 2013, Nucleic Acids Res..

[47]  Ying Li,et al.  Complex of NS3 protease and NS4A peptide of BK strain hepatitis C virus: A 2.2 Å resolution structure in a hexagonal crystal form , 1998, Protein science : a publication of the Protein Society.

[48]  Zheng Rong Yang,et al.  RONN: the bio-basis function neural network technique applied to the detection of natively disordered regions in proteins , 2005, Bioinform..

[49]  U. Egerland,et al.  Highly potent, selective, and orally active phosphodiesterase 10A inhibitors. , 2011, Journal of medicinal chemistry.

[50]  S. Venkatesh,et al.  Aqueous and cosolvent solubility data for drug-like organic compounds , 2005, The AAPS Journal.

[51]  E. Pasquale,et al.  Structure of ERK2 bound to PEA-15 reveals a mechanism for rapid release of activated MAPK , 2013, Nature Communications.

[52]  R. Bürli,et al.  Design, synthesis, and biological evaluation of potent and selective class IIa histone deacetylase (HDAC) inhibitors as a potential therapy for Huntington's disease. , 2013, Journal of medicinal chemistry.

[53]  T. Golub,et al.  A Maltose-Binding Protein Fusion Construct Yields a Robust Crystallography Platform for MCL1 , 2015, PloS one.

[54]  E. Birney,et al.  Pfam: the protein families database , 2013, Nucleic Acids Res..

[55]  David Eisenberg,et al.  Toward rational protein crystallization: A Web server for the design of crystallizable protein variants , 2007, Protein science : a publication of the Protein Society.

[56]  M. Mayer,et al.  Conformational analysis of NMDA receptor GluN1, GluN2, and GluN3 ligand-binding domains reveals subtype-specific characteristics. , 2013, Structure.

[57]  김삼묘,et al.  “Bioinformatics” 특집을 내면서 , 2000 .

[58]  K. Gunsalus,et al.  Protein production and purification , 2008, Nature Methods.

[59]  Lisa M. Shewchuk,et al.  Crystallization of protein–ligand complexes , 2006, Acta crystallographica. Section D, Biological crystallography.

[60]  Zygmunt S Derewenda,et al.  Rational protein crystallization by mutational surface engineering. , 2004, Structure.

[61]  L. Christophorou.  Science , 2018, Emerging Dynamics: Science, Energy, Society and Values.

[62]  S. McNicholas,et al.  Presenting your structures: the CCP4mg molecular-graphics software , 2011, Acta crystallographica. Section D, Biological crystallography.

[63]  John Kuriyan,et al.  A Src-Like Inactive Conformation in the Abl Tyrosine Kinase Domain , 2006, PLoS biology.

[64]  Martin Hammarström,et al.  Rapid screening for improved solubility of small human proteins produced as fusion proteins in Escherichia coli , 2002, Protein science : a publication of the Protein Society.

[65]  A. Megens,et al.  Discovery of a potent, selective, and orally active phosphodiesterase 10A inhibitor for the potential treatment of schizophrenia. , 2014, Journal of medicinal chemistry.

[66]  Janet Newman,et al.  Towards rationalization of crystallization screening for small- to medium-sized academic laboratories: the PACT/JCSG+ strategy. , 2005, Acta crystallographica. Section D, Biological crystallography.

[67]  George Kontopidis,et al.  Statistical approaches to maximize recombinant protein expression in Escherichia coli: a general review. , 2014, Protein expression and purification.

[68]  Per Kraulis,et al.  A software tool to accelerate design of protein constructs for recombinant expression. , 2010, Protein expression and purification.

[69]  Jin Hwan Kim,et al.  Structure of the catalytic domain of human phosphodiesterase 5 with bound drug molecules , 2003, Nature.

[70]  P. Nordlund,et al.  Chemical screening methods to identify ligands that promote protein stability, protein crystallization, and structure determination , 2006, Proceedings of the National Academy of Sciences.

[71]  J. Ng,et al.  Lessons from ten years of crystallization experiments at the SGC , 2016, Acta crystallographica. Section D, Structural biology.